跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 37 条关于
“TNSALP”
全部
37
临床试验
18
药物
3
机构
1
资讯
15
去年
Be Biopharma to Present Promising Nonclinical Data for Novel B Cell Therapy in Hypophosphatasia Treatment
去年
AstraZeneca Discontinues Two Alexion Rare Disease Programs Amid Strong Q4 Performance
3个月前
Hypophosphatasia Market Poised for Robust Growth Through 2036 as Next-Generation Therapies Advance
3个月前
Upstream Bio to Present Novel TSLP Antagonist Verekitug at Goldman Sachs Healthcare Conference
2年前
GSK Acquires Aiolos Bio for $1.4B, Expanding Asthma Treatment Portfolio with Novel TSLP Inhibitor
6个月前
Harbour BioMed's TSLP-Targeting Antibody HBM9378 Shows Favorable Safety Profile in Phase I Trial
去年
Windward Bio Secures Global License for Anti-TSLP Antibody SKB378/HBM9378 in $970M Deal
2个月前
NMPA Clears IND for HBM7575/SKB575, a Long-Acting TSLP Bispecific Antibody for Asthma
去年
Upstream Bio Presents Data Showing Verekitug's Superior Potency Through TSLP Receptor Targeting at EAACI Congress
2年前
Blackstone Launches Uniquity Bio with $300M to Advance Anti-TSLP Therapy for Asthma and COPD
第 1 页,共 2 页
上一页
下一页